Sunday, October 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· December 8, 2025

Global AI-Powered Humanoid Robots Market Size Expected to Reach $7.73 Billion as Engineering Drastically Improves

View original at globenewswire.com
Global AI-Powered Humanoid Robots Market Size Expected to Reach $7.73 Billion as Engineering Drastically Improves MarketNewsUpdatesNews Commentary PALM BEACH, Fla., Dec…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Generative AI uniquely important technology for robotics because it unlocks general functionality, unlike traditional robots trained intensively on specific tasks

    80% confidence
  • Global AI-powered Humanoid Robots Market size expected to reach $7,739.0 Million by 2034, from $352.3 Million in 2024, growing at CAGR of 36.2% during forecast period 2025-2034

    80% confidence
  • Robots today are highly bespoke and difficult to deploy, often taking many months to install single cell that can do single task

    80% confidence
  • Investment opportunities abundant with significant growth potential in healthcare, manufacturing, and entertainment sectors

    80% confidence
  • Marc Theermann brings deep industry experience across embodied AI and advanced robotics, perspective on commercialization and platform development will be valuable

    80% confidence
  • Partnership with Synopsys harnesses NVIDIA accelerated computing and AI to reimagine engineering and design, empowering engineers to invent extraordinary products

    80% confidence
  • White House considering executive order in 2026 to back humanoid robotics with funding or incentives, which could accelerate deployment and adoption

    80% confidence
  • Expansion fueled by rising need for automation, labor shortages, and potential for robots to perform hazardous or monotonous tasks

    80% confidence
  • Excited to join Humanoid Global at moment when robotics is scaling faster than ever, opportunity to help democratize access to sector for institutional and private investors

    80% confidence
  • CUDA GPU-accelerated computing revolutionizing design, enabling simulation at unprecedented speed and scale, creating fully functional digital twins inside computer

    80% confidence
  • Robotics increasingly viewed as strategic area of competition with China, prompting companies to seek federal support for automation, supply chains and rollouts

    80% confidence
  • In 2024, North America held dominant market position, capturing more than 53.4% share, holding $188.0 Million revenue

    80% confidence
  • Asia-Pacific region led by Japan, South Korea, and China witnessing robust growth due to substantial investments in robotics and AI technologies

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com